# TAP Block for Postoperative Pain Control

> **NCT02652156** · PHASE3 · TERMINATED · sponsor: **Joshua Herskovic** · enrollment: 14 (actual)

## Conditions studied

- Pain, Postoperative

## Interventions

- **DRUG:** Bupivacaine
- **DRUG:** Exparel®
- **DRUG:** Ropivacaine

## Key facts

- **NCT ID:** NCT02652156
- **Lead sponsor:** Joshua Herskovic
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-11-01
- **Primary completion:** 2016-04-16
- **Final completion:** 2016-04-16
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** Operational barriers at the site.
- **Last updated:** 2018-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02652156

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02652156, "TAP Block for Postoperative Pain Control". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02652156. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*